YICHAO ZHANG: Open Payments
NPI 1508482282 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 74 payments from 14 companies in 2025. Trend: 2023 $45 · 2024 $89 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $325 |
| ABBVIE INC. | 12 | $206 |
| E.R. Squibb & Sons, L.L.C. | 8 | $161 |
| Axsome Therapeutics, Inc. | 13 | $155 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Biogen, Inc. | 4 | $79 |
| Lundbeck LLC | 2 | $64 |
| Corium, LLC | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
Products named: CAPLYTA, VRAYLAR, COBENFY, Auvelity, INGREZZA, REXULTI, ZURZUVAE, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
